133 related articles for article (PubMed ID: 18338921)
1. [Protease and phospholipase activities of Candida albicans isolated from vaginal secretions with different pH values].
Ombrella AM; Racca L; Ramos L
Rev Iberoam Micol; 2008 Mar; 25(1):12-6. PubMed ID: 18338921
[TBL] [Abstract][Full Text] [Related]
2. Detection of phospholipase activity of Candida albicans and non albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area.
Fule SR; Das D; Fule RP
Indian J Med Microbiol; 2015; 33(1):92-5. PubMed ID: 25560009
[TBL] [Abstract][Full Text] [Related]
3. Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis.
Ramos Lde S; Barbedo LS; Braga-Silva LA; dos Santos AL; Pinto MR; Sgarbi DB
Rev Iberoam Micol; 2015; 32(2):122-5. PubMed ID: 24853474
[TBL] [Abstract][Full Text] [Related]
4. [Isolation of Gardnerella vaginalis from vaginal discharge specimens].
Köksalan H; Esen N; Cağatay M; Tülek N; Mert A
Mikrobiyol Bul; 1993 Jul; 27(3):191-5. PubMed ID: 8361406
[TBL] [Abstract][Full Text] [Related]
5. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis.
Jafari M; Salari S; Pakshir K; Zomorodian K
Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of virulence factors of Candida albicans isolated from HIV-positive individuals using HAART.
de Paula Menezes R; de Melo Riceto ÉB; Borges AS; de Brito Röder DV; dos Santos Pedroso R
Arch Oral Biol; 2016 Jun; 66():61-5. PubMed ID: 26913969
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase and proteinase activities of Candida spp. isolates from vulvovaginitis in Iran.
Shirkhani S; Sepahvand A; Mirzaee M; Anbari K
J Mycol Med; 2016 Sep; 26(3):255-60. PubMed ID: 27544321
[TBL] [Abstract][Full Text] [Related]
8. Comparison of enzymatic activities in different Candida species isolated from women with vulvovaginitis.
Fatahinia M; Halvaeezadeh M; Rezaei-Matehkolaei A
J Mycol Med; 2017 Jun; 27(2):188-194. PubMed ID: 28236530
[TBL] [Abstract][Full Text] [Related]
9. Characterization of virulence factors of vaginal and anal isolates of Candida albicans sequentially obtained from patients with vulvovaginal candidiasis in north-east Brazil.
Araújo Paulo de Medeiros M; Vieira de Melo AP; Maia de Sousa AM; Silva-Rocha WP; Pipolo Milan E; Maranhão Chaves G
J Mycol Med; 2017 Dec; 27(4):567-572. PubMed ID: 28844452
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase and Aspartyl Proteinase Activities of Candida Species Causing Vulvovaginal Candidiasis in Patients with Type 2 Diabetes Mellitus.
Bassyouni RH; Wegdan AA; Abdelmoneim A; Said W; AboElnaga F
J Microbiol Biotechnol; 2015 Oct; 25(10):1734-41. PubMed ID: 26032358
[TBL] [Abstract][Full Text] [Related]
11. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens.
El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603
[TBL] [Abstract][Full Text] [Related]
12. [Proteolytic activity of Candida albicans strains isolated from women's genital organs with clinical diagnosis of mycosis].
Rózga A; Kurnatowska A; Gołab-Lipińska M
Wiad Parazytol; 2001; 47 Suppl 1():125-9. PubMed ID: 16897963
[TBL] [Abstract][Full Text] [Related]
13. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Albicans ID2 and Biggy agar for the isolation and direct identification of vaginal yeast isolates.
Ilkit M; Hilmioglu S; Tasbakan M; Aydemir S
J Med Microbiol; 2007 Jun; 56(Pt 6):762-765. PubMed ID: 17510260
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis].
Martínez-García A; Cejudo-Alvarez J; Bravo-Topete EG; Herrera-Villalobos JE; Garibay-Valencia M; Mirabent-González F
Ginecol Obstet Mex; 2011 Feb; 79(2):75-85. PubMed ID: 21966787
[TBL] [Abstract][Full Text] [Related]
17. Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
Novikova N; Rodrigues A; Mårdh PA
Infect Dis Obstet Gynecol; 2002; 10(2):89-92. PubMed ID: 12530485
[TBL] [Abstract][Full Text] [Related]
18. [Phenotypic evaluation to differentiate Candida albicans from Candida dubliniensis].
Mesa LM; Arcaya N; Cañas O; Machado Y; Calvo B
Rev Iberoam Micol; 2004 Sep; 21(3):135-8. PubMed ID: 15709787
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral antiseptic agents on phospholipase and proteinase enzymes of Candida albicans.
Uygun-Can B; Kadir T; Gumru B
Arch Oral Biol; 2016 Feb; 62():20-7. PubMed ID: 26615573
[TBL] [Abstract][Full Text] [Related]
20. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review.
Kalia N; Singh J; Kaur M
Ann Clin Microbiol Antimicrob; 2020 Jan; 19(1):5. PubMed ID: 31992328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
